Perbedaan Lavender Bina Cendikia Tbk. dan Merck Tbk.: Lavender Bina Cendikia Tbk. diperdagangkan di Rp30 (kapitalisasi pasar 30,9 M, volume 24 jam 2,96 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.800 (kapitalisasi pasar 1,68 T, volume 24 jam 33,3 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 54,4× kapitalisasi pasar Lavender Bina Cendikia Tbk., dan Lavender Bina Cendikia Tbk. lebih aktif diperdagangkan (2,96 jt vs 33,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BMBL | MERK | |
|---|---|---|
Kapitalisasi Pasar | 30,9 M | 1,68 T |
Volume | 2,96 jt | 33,3 rb |
Lot | 29,64 rb | 333 |
Perputaran | 88,75 jt | 126,46 jt |
Harga Rata-rata | 29,94 | 3.797,72 |
Nilai Transaksi | 88,75 jt | 126,46 jt |
Harga Ekuilibrium Indikatif | 30 | 3.800 |
Volume Ekuilibrium Indikatif | 1 | 9 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Lavender Bina Cendikia Tbk ("Company") was established on November 27, 2013 based on theNotarial deed of Suparman Hasyim, S.H., No. 35. The Company started its commercial operations in2013. The ultimate beneficial owner of the Company is Galih Pandekar.
Selengkapnya di halaman BMBL →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →